82 related articles for article (PubMed ID: 26656426)
1. Down-Regulation of Nogo-B Expression as a Newly Identified Feature of Intrahepatic Cholangiocarcinoma.
Nanashima A; Hatachi G; Tominaga T; Murakami G; Takagi K; Arai J; Wada H; Nagayasu T; Sumida Y
Tohoku J Exp Med; 2016 Jan; 238(1):9-16. PubMed ID: 26656426
[TBL] [Abstract][Full Text] [Related]
2. Relationship between microvessel count and postoperative survival in patients with intrahepatic cholangiocarcinoma.
Nanashima A; Shibata K; Nakayama T; Tobinaga S; Araki M; Kunizaki M; Takeshita H; Hidaka S; Sawai T; Nagayasu T; Tagawa T
Ann Surg Oncol; 2009 Aug; 16(8):2123-9. PubMed ID: 19434454
[TBL] [Abstract][Full Text] [Related]
3. Clinical significances of cancer stem cells markers in patients with intrahepatic cholangiocarcinoma who underwent hepatectomy.
Nanashima A; Hatachi G; Tsuchiya T; Matsumoto H; Arai J; Abo T; Murakami G; Tominaga T; Takagi K; Nagayasu T
Anticancer Res; 2013 May; 33(5):2107-14. PubMed ID: 23645762
[TBL] [Abstract][Full Text] [Related]
4. Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.
Imai K; Yamamoto M; Ariizumi S
Hepatogastroenterology; 2010; 57(104):1333-6. PubMed ID: 21443080
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma.
Jeong CY; Hah YS; Cho BI; Lee SM; Joo YT; Jung EJ; Jeong SH; Lee YJ; Choi SK; Ha WS; Park ST; Hong SC
Oncol Rep; 2012 Oct; 28(4):1283-92. PubMed ID: 22825302
[TBL] [Abstract][Full Text] [Related]
6. Decreased roundabout 1 expression promotes development of intrahepatic cholangiocarcinoma.
Mano Y; Aishima S; Fukuhara T; Tanaka Y; Kubo Y; Motomura T; Toshima T; Iguchi T; Shirabe K; Maehara Y; Oda Y
Hum Pathol; 2013 Nov; 44(11):2419-26. PubMed ID: 23953227
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
Li J; Wang Q; Lei Z; Wu D; Si A; Wang K; Wan X; Wang Y; Yan Z; Xia Y; Lau WY; Wu M; Shen F
Oncologist; 2015 Jun; 20(6):640-7. PubMed ID: 25956404
[TBL] [Abstract][Full Text] [Related]
8. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
Ohtsuka M; Ito H; Kimura F; Shimizu H; Togawa A; Yoshidome H; Miyazaki M
Br J Surg; 2002 Dec; 89(12):1525-31. PubMed ID: 12445060
[TBL] [Abstract][Full Text] [Related]
9. [Two cases of long-term survival after treatment of recurrent intrahepatic cholangiocarcinoma and intrahepatic metastasis in the remnant liver with repeated hepatectomy].
Matsukawa H; Fujiwara Y; Satoh D; Shiozaki S; Ohno S; Hamada M; Ojima Y; Harano M; Kanazawa T; Choda Y; Okajima M; Ninomiya M
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1828-30. PubMed ID: 24393936
[TBL] [Abstract][Full Text] [Related]
10. Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy.
Abe T; Amano H; Shimamoto F; Hattori M; Kuroda S; Kobayashi T; Tashiro H; Ohdan H
Eur J Surg Oncol; 2015 Nov; 41(11):1515-21. PubMed ID: 26210654
[TBL] [Abstract][Full Text] [Related]
11. First and repeat liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
Souche R; Addeo P; Oussoultzoglou E; Herrero A; Rosso E; Navarro F; Fabre JM; Bachellier P
Am J Surg; 2016 Aug; 212(2):221-9. PubMed ID: 26552996
[TBL] [Abstract][Full Text] [Related]
12. Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor.
Ariizumi S; Kotera Y; Katagiri S; Nakano M; Yamamoto M
Ann Surg Oncol; 2012 May; 19(5):1628-36. PubMed ID: 22113592
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes and apomucin expression of intrahepatic cholangiocarcinoma according to gross morphology.
Suh KS; Chang SH; Lee HJ; Roh HR; Kim SH; Lee KU
J Am Coll Surg; 2002 Dec; 195(6):782-9. PubMed ID: 12495310
[TBL] [Abstract][Full Text] [Related]
14. Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study.
Zhao Q; Yu WL; Lu XY; Dong H; Gu YJ; Sheng X; Cong WM; Wu MC
Chin J Cancer; 2016 Aug; 35(1):82. PubMed ID: 27552844
[TBL] [Abstract][Full Text] [Related]
15. Loss of liver-intestine cadherin in human intrahepatic cholangiocarcinoma promotes angiogenesis by up-regulating metal-responsive transcription factor-1 and placental growth factor.
Takamura M; Yamagiwa S; Wakai T; Tamura Y; Kamimura H; Kato T; Tsuchiya A; Matsuda Y; Shirai Y; Ichida T; Ajioka Y; Aoyagi Y
Int J Oncol; 2010 Jan; 36(1):245-54. PubMed ID: 19956853
[TBL] [Abstract][Full Text] [Related]
16. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
[TBL] [Abstract][Full Text] [Related]
17. ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma.
Terashita K; Chuma M; Hatanaka Y; Hatanaka K; Mitsuhashi T; Yokoo H; Ohmura T; Ishizu H; Muraoka S; Nagasaka A; Tsuji T; Yamamoto Y; Kurauchi N; Shimoyama N; Toyoda H; Kumada T; Kaneoka Y; Maeda A; Ogawa K; Natsuizaka M; Kamachi H; Kakisaka T; Kamiyama T; Taketomi A; Matsuno Y; Sakamoto N
J Clin Pathol; 2016 Jul; 69(7):593-9. PubMed ID: 26670746
[TBL] [Abstract][Full Text] [Related]
18. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S
Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
[TBL] [Abstract][Full Text] [Related]
19. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
